Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 6
Submit an article Journal homepage
74
Views
2
CrossRef citations to date
0
Altmetric
Letters

Very poor outcome of leukemic transformation in myelofibrosis: a single center experience with 13 patients

Grzegorz HelbigDepartment of Hematology and Bone Marrow TransplantationCorrespondence[email protected]
,
Agata Wieczorkiewicz-KabutDepartment of Hematology and Bone Marrow Transplantation
,
Jacek PajakDepartment of Pathology, Silesian Medical University, Katowice, Poland
,
Agnieszka WieclawekDepartment of Hematology and Bone Marrow Transplantation
,
Małgorzata StachowiczDepartment of Hematology and Bone Marrow Transplantation
,
Anna SojaDepartment of Hematology and Bone Marrow Transplantation
,
Anna RusekDepartment of Hematology and Bone Marrow Transplantation
,
Agnieszka KarolczykDepartment of Hematology and Bone Marrow Transplantation
,
Aleksandra Bartkowska-ChrobokDepartment of Hematology and Bone Marrow Transplantation
&
Sławomira Kyrcz-KrzemienDepartment of Hematology and Bone Marrow Transplantation
 show all
Pages 1236-1238 | Received 26 Oct 2011, Accepted 13 Nov 2011, Published online: 03 Jan 2012

References

  • Barosi G. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 1999;17:2954–2970.
  • Dupriez B, Morel P, Demory JL, . Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 1996;88:1013–1018.
  • Mesa RA, Li CY, Ketterling RP, . Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood 2005;105:973–977.
  • Thiele J, Kvasnicka M. Grade of bone marrow fibrosis is associated with relevant hematological findings - a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis. Ann Hematol 2006;85:226–232.
  • Cervantes F, Dupriez B, Pereira A, . New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood 2009;113:2895–2901.
  • Cervantes F, Tassies D, Salgado C, . Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients. Acta Haematol 1991;85:124–127.
  • Tefferi A, Huang J, Schwager S, . Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution. Cancer 2007;109:2083–2088.
  • Huang J, Li CY, Mesa RA, . Risk factors for leukemic transformation in patients with primary myelofibrosis. Cancer 2008;112:2726–2732.
  • Morel P, Duhamel A, Hivert B, . Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients. Blood 2010;115:4350–4355.
  • Mesa RA, Powell H, Lasho T, . JAK2V617F and leukemic transformation in myelofibrosis with myeloid metaplasia. Leuk Res 2006;30:1457–1460.
  • Barosi G, Bergamaschi G, Marchetti M, . JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. Blood 2007;110:4030–4036.
  • Tefferi A, Jimma T, Sulai NH, . IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukomogenic collaboration with JAK2V617F. Leukemia 2011 Sep 13. [Epub ahead of print]
  • Tam CS, Nussenzveig RM, Popat U, . The natural history and treatment outcome of blast phase BCR-ABL-myeloproliferative neoplasms. Blood 2008;112:1628–1637.
  • Ciurea SO, de Lima M, Giralt S, . Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation. Biol Blood Marrow Transplant 2010;16:555–559.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.